Use of Biologics to Treat Relapsing and/or Refractory Eosinophilic Granulomatosis with Polyangiitis: data from a European Collaborative Study

This retrospective European collaborative study (n=147) found rituximab (n=63) may be effective in the treatment of vasculitis relapses (median BVAS falling from 8.5 at inclusion to 1 at 6 months and 0 at 12 months); further confirmatory data are required.

Source:

Arthritis & Rheumatology